Transdermal drug delivery is a self-discrete dosage forms, which applied on the intact skin deliver the drug at controlled rate to the systemic circulation.

Transdermal Drug Delivery System market is growing at a CAGR of 5.5% in Asia-Pacific, followed by North America and Europe, with 4.3 % and 4.2% CAGR, respectively.
High prevalence of chronic diseases across the globe is the key factor in accelerating market growth during the forecast period across all regions, global Pain Management segment, USA, Canada, Japan, China and Europe will drive the growth post Covid-19, Home care settings segment is expected to grow at the fastest rate during the forecast period , attributed to the increase in self-administration of medication at home, rapid growth in the geriatric population across the globe, and the growing need for cost-effective drug administration.
Beneficial features like non-invasiveness, lower pain sensations in patients, complete administration of a dose, and ease of treatment termination are also driving this market.